On-Demand Webinar Archives

On-Demand Webinar

PBPK Modeling of Antibody-Drug Conjugates – Concept and Application

Antibody-Drug Conjugates (ADCs) can be an ideal drug treatment for cancer because they deliver a…

CertaraJanuary 13, 2022

On-Demand Webinar

Certara University Express Webinar: Part 2: Introduction to RsNLME and overview of expanded workflow

Introduction to RsNLME and its capabilities for population PK/PD modeling.

CertaraJanuary 5, 2022

On-Demand Webinar

Certara University Express Webinar: Part 1: Introduction to RsNLME (R speaks NLME)

Introduction to RsNLME and its capabilities for population PK/PD modeling.

CertaraJanuary 5, 2022

On-Demand Webinar

Strategic Application of PBPK Modeling for Predicting DDIs & the Effects of Smoking & Organ Impairment

Olanzapine is a highly effective antipsychotic, but its uses are limited by the risk of…

CertaraDecember 23, 2021

On-Demand Webinar

Exploring Changes in SDTMIG 3.4 & ADaMIG 1.3

On November 29th 2021, CDISC released updated versions of SDTM and ADaM, including standardized structures…

CertaraDecember 16, 2021

On-Demand Webinar

Predicting and Taming Immunogenicity: Strategies for your Biologic Drug

Immunogenicity is the ability of a foreign substance, such as a drug or vaccine, to…

CertaraNovember 19, 2021

On-Demand Webinar

External Control Arms – The Case for a Standardized Lexicon and Toolkit

Both the FDA and EMA have made statements that support the concept of using real…

CertaraOctober 12, 2021

On-Demand Webinar

Model-based DDI Extrapolation Strategy from Adults to Children – A Case Study with Risdiplam

Risdiplam (EVRYSDI) is approved for the treatment of patients with spinal muscular atrophy ≥ 2…

CertaraOctober 7, 2021

On-Demand Webinar

FDA’s Digital Transformation: The Future of Technology and How to Prepare

As Life-Science manufacturers embrace new technologies to speed time to market and products become more…

CertaraOctober 5, 2021

On-Demand Webinar

The Scary Future of Rare Disease Management

In a world of rising healthcare costs, the greatest nightmare for payers is reimbursing drug…

CertaraSeptember 23, 2021

On-Demand Webinar

PBPK Modeling of Antibody-Drug Conjugates – Concept and Application

Certara University Express Webinar: Part 2: Introduction to RsNLME and overview of expanded workflow

Certara University Express Webinar: Part 1: Introduction to RsNLME (R speaks NLME)

Strategic Application of PBPK Modeling for Predicting DDIs & the Effects of Smoking & Organ Impairment

Exploring Changes in SDTMIG 3.4 & ADaMIG 1.3

Predicting and Taming Immunogenicity: Strategies for your Biologic Drug

External Control Arms – The Case for a Standardized Lexicon and Toolkit

Model-based DDI Extrapolation Strategy from Adults to Children – A Case Study with Risdiplam

FDA’s Digital Transformation: The Future of Technology and How to Prepare

The Scary Future of Rare Disease Management

Newsletter sign up

Quick links

Solutions

Contact